Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by, and welcome to Kara Therapeutics' fourth quarter and full year 2023 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. To remove yourself from the question queue, you may press star 1 1 again. I would now like to hand the call over to Matt Murphy, Manager of Investor Relations. Please go ahead. Thank you, Operator, and good afternoon. After market closed today, CARA issued a news release announcing the company's financial and operating results for the fourth quarter and full year 2023. Copies of this news release can be found in the Investor section of our website at caratherapeutics.com. Before we begin, let me remind you that during the course of this conference call, we will be making certain forward-looking statements about CARA and our program based on management's current plans and expectations. These statements are being made under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties. Actual results may differ materially due to various factors, and CARA undertakes no obligation to update or revise these statements publicly as a result of new information or future results or developments. Investors should read the risk factors set forth in CARES 10-K for the year ended December 31st, 2022, and any subsequent reports filed with the SEC, including its Form 10-Q for the quarter ended September 30th, 2023. With that said, I'd like to turn the call over to Chris Posner, CARES Chief Executive Officer. Chris? Thanks, Matt. Good afternoon, and thank you for joining our call. With me today are Ryan Maynard...